107 related articles for article (PubMed ID: 11575702)
1. BMS-232632 (Novartis/Bristol-Myers Squibb).
Witherell G
Curr Opin Investig Drugs; 2001 Mar; 2(3):340-7. PubMed ID: 11575702
[TBL] [Abstract][Full Text] [Related]
2. BMS-204352 (Bristol Myers Squibb).
Mackay KB
Curr Opin Investig Drugs; 2001 Jun; 2(6):820-3. PubMed ID: 11572663
[TBL] [Abstract][Full Text] [Related]
3. Brasofensine NeuroSearch.
Yu P
Curr Opin Investig Drugs; 2000 Dec; 1(4):504-7. PubMed ID: 11249705
[TBL] [Abstract][Full Text] [Related]
4. BMS-275291. Bristol-Myers Squibb.
Poulaki V
Curr Opin Investig Drugs; 2002 Mar; 3(3):500-4. PubMed ID: 12054103
[TBL] [Abstract][Full Text] [Related]
5. Exubera. Inhale therapeutic systems.
Bindra S; Cefalu WT
Curr Opin Investig Drugs; 2002 May; 3(5):758-62. PubMed ID: 12090549
[TBL] [Abstract][Full Text] [Related]
6. Iloperidone (Novartis).
Hesselink JM
IDrugs; 2002 Jan; 5(1):84-90. PubMed ID: 12861482
[TBL] [Abstract][Full Text] [Related]
7. A new protease inhibitor from Bristol-Myers Squibb.
TreatmentUpdate; 2001; 12(12):5. PubMed ID: 11570092
[No Abstract] [Full Text] [Related]
8. GMK (Progenics Pharmaceuticals).
Knutson KL
Curr Opin Investig Drugs; 2002 Jan; 3(1):159-64. PubMed ID: 12054067
[TBL] [Abstract][Full Text] [Related]
9. Omapatrilat. Bristol-Myers Squibb.
Tabrizchi R
Curr Opin Investig Drugs; 2001 Oct; 2(10):1414-22. PubMed ID: 11890357
[TBL] [Abstract][Full Text] [Related]
10. DAPD (Emory University/Triangle Pharmaceuticals/Abbott Laboratories).
Corbett AH; Rublein JC
Curr Opin Investig Drugs; 2001 Mar; 2(3):348-53. PubMed ID: 11575703
[TBL] [Abstract][Full Text] [Related]
11. BMS-193884 and BMS-207940 Bristol-Myers Squibb.
Hulpke-Wette M; Buchhorn R
Curr Opin Investig Drugs; 2002 Jul; 3(7):1057-61. PubMed ID: 12186267
[TBL] [Abstract][Full Text] [Related]
12. Valdecoxib (Pharmacia).
Gotta AW
Curr Opin Investig Drugs; 2002 Feb; 3(2):240-5. PubMed ID: 12020053
[TBL] [Abstract][Full Text] [Related]
13. BMS-247550 Bristol-Myers Squibb/GBF.
Lin N; Brakora K; Seiden M
Curr Opin Investig Drugs; 2003 Jun; 4(6):746-56. PubMed ID: 12901236
[TBL] [Abstract][Full Text] [Related]
14. Repinotan Bayer.
Lutsep HL
Curr Opin Investig Drugs; 2002 Jun; 3(6):924-7. PubMed ID: 12137415
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
16. Etanercept Immunex.
Yung RL
Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
[TBL] [Abstract][Full Text] [Related]
17. Ximelagatran (AstraZeneca).
Hopfner R
Curr Opin Investig Drugs; 2002 Feb; 3(2):246-51. PubMed ID: 12020054
[TBL] [Abstract][Full Text] [Related]
18. Dalbavancin (Biosearch Italia/Versicor).
Steiert M; Schmitz FJ
Curr Opin Investig Drugs; 2002 Feb; 3(2):229-33. PubMed ID: 12020051
[TBL] [Abstract][Full Text] [Related]
19. Pleconaril Sanofi Synthélabo/ViroPharma.
Billich A
Curr Opin Investig Drugs; 2000 Nov; 1(3):303-7. PubMed ID: 11249712
[TBL] [Abstract][Full Text] [Related]
20. ZD-1839 (AstraZeneca).
Norman P
Curr Opin Investig Drugs; 2001 Mar; 2(3):428-34. PubMed ID: 11575718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
